Kala Pharmaceuticals Reports Second Quarter 2019 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. LEVI
2. SBUX
3. NVDA
4. SPCX
5. SPY
6. GOOGL
7. APLD
8. USO
9. STZ
10. AAPL

Go back to Kala Pharmaceuticals Reports Second Quarter 2019 Financial Results

Kala Pharmaceuticals (KALA) Tops Q2 EPS by 3c

August 6, 2019 7:58 AM EDT

Kala Pharmaceuticals (NASDAQ: KALA) reported Q2 EPS of ($0.70), $0.03 better than the analyst estimate of ($0.73). Revenue for the quarter came in at $2.1 million versus the consensus estimate of $2.69 million.

For earnings history and earnings-related data on Kala Pharmaceuticals (KALA) click here.

... More